Yi-Chyan Chen

707 total citations
26 papers, 560 citations indexed

About

Yi-Chyan Chen is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Yi-Chyan Chen has authored 26 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 10 papers in Pharmacology and 6 papers in Biological Psychiatry. Recurrent topics in Yi-Chyan Chen's work include Neuroscience and Neuropharmacology Research (8 papers), Tryptophan and brain disorders (6 papers) and Treatment of Major Depression (6 papers). Yi-Chyan Chen is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Tryptophan and brain disorders (6 papers) and Treatment of Major Depression (6 papers). Yi-Chyan Chen collaborates with scholars based in Taiwan, United States and United Kingdom. Yi-Chyan Chen's co-authors include Yi‐Jen Hung, Shih‐Jiun Yin, Giia‐Sheun Peng, Ming-Fang Wang, Andrew Holmes, Tien‐Ping Tsao, Hwei‐Hsien Chen, Ming‐Huan Chan, Rose‐Marie Karlsson and Chien-Hsing Lee and has published in prestigious journals such as Neuropsychopharmacology, Journal of Affective Disorders and Psychopharmacology.

In The Last Decade

Yi-Chyan Chen

25 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi-Chyan Chen Taiwan 15 165 148 122 102 93 26 560
Nuria García‐Marchena Spain 15 182 1.1× 165 1.1× 95 0.8× 92 0.9× 49 0.5× 35 558
Curtis A. Benson United States 13 106 0.6× 71 0.5× 97 0.8× 147 1.4× 110 1.2× 22 576
Sixun Yu China 14 211 1.3× 105 0.7× 230 1.9× 28 0.3× 70 0.8× 31 801
Michal Taler Israel 16 214 1.3× 255 1.7× 203 1.7× 36 0.4× 198 2.1× 37 835
Nóra Török Hungary 14 62 0.4× 176 1.2× 118 1.0× 69 0.7× 89 1.0× 20 504
Arezo Nahavandi Iran 16 133 0.8× 77 0.5× 104 0.9× 24 0.2× 103 1.1× 33 556
Xu Wu China 16 189 1.1× 223 1.5× 249 2.0× 39 0.4× 63 0.7× 49 865
Timothy Fabisiak United States 8 212 1.3× 103 0.7× 184 1.5× 35 0.3× 63 0.7× 10 686
Elisa Bisicchia Italy 15 185 1.1× 76 0.5× 241 2.0× 101 1.0× 71 0.8× 23 835
Joan B. O’Sullivan Ireland 8 95 0.6× 286 1.9× 113 0.9× 26 0.3× 196 2.1× 10 717

Countries citing papers authored by Yi-Chyan Chen

Since Specialization
Citations

This map shows the geographic impact of Yi-Chyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Chyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Chyan Chen more than expected).

Fields of papers citing papers by Yi-Chyan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-Chyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Chyan Chen. The network helps show where Yi-Chyan Chen may publish in the future.

Co-authorship network of co-authors of Yi-Chyan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yi-Chyan Chen. A scholar is included among the top collaborators of Yi-Chyan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi-Chyan Chen. Yi-Chyan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tzeng, I‐Shiang, et al.. (2025). Gastrodin Mitigates Ketamine-Induced Inhibition of F-Actin Remodeling and Cell Migration by Regulating the Rho Signaling Pathway. Biomedicines. 13(3). 649–649. 1 indexed citations
2.
3.
Chang, Fang‐Yu, et al.. (2023). Age, Dose, and Locomotion: Decoding Vulnerability to Ketamine in C57BL/6J and BALB/c Mice. Biomedicines. 11(7). 1821–1821. 4 indexed citations
4.
Chen, Po‐An, et al.. (2022). Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice. Behavioural Neurology. 2022. 1–12. 5 indexed citations
5.
Chen, Yi-Chyan, Fu‐Ming Tsai, & Mao‐Liang Chen. (2020). Antipsychotic Drugs Reverse MK801-Inhibited Cell Migration and F-actin Condensation by Modulating the Rho Signaling Pathway in B35 Cells. Behavioural Neurology. 2020. 1–9. 6 indexed citations
6.
Chan, Ming‐Huan, et al.. (2016). N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 71. 7–13. 25 indexed citations
7.
Chan, Ming‐Huan, et al.. (2016). Betaine enhances antidepressant-like, but blocks psychotomimetic effects of ketamine in mice. Psychopharmacology. 233(17). 3223–3235. 32 indexed citations
8.
9.
Yao, Chung‐Tay, Chun‐An Cheng, Hsu-Kun Wang, et al.. (2011). The role of ALDH2 and ADH1B polymorphism in alcohol consumption and stroke in Han Chinese. Human Genomics. 5(6). 569–569. 32 indexed citations
10.
Camp, Marguerite, Michael Feyder, Jessica Ihne, et al.. (2011). A novel role for PSD-95 in mediating ethanol intoxication, drinking and place preference. Addiction Biology. 16(3). 428–439. 42 indexed citations
11.
Liu, Pang‐Yen, et al.. (2010). Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome. General Hospital Psychiatry. 33(1). 84.e5–84.e7. 6 indexed citations
12.
Chen, Chun‐Yen, Nian‐Sheng Tzeng, & Yi-Chyan Chen. (2010). Maintenance therapy of celecoxib for major depression with mimicking neuropsychological dysfunction. General Hospital Psychiatry. 32(6). 647.e7–647.e9. 20 indexed citations
13.
Fitzgerald, Paul J., Chris Barkus, Michael Feyder, et al.. (2010). Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder?. Neurobiology of Disease. 40(3). 608–621. 67 indexed citations
14.
Chen, Yi-Chyan & Andrew Holmes. (2008). Effects of Topiramate and Other Anti-Glutamatergic Drugs on the Acute Intoxicating Actions of Ethanol in Mice: Modulation by Genetic Strain and Stress. Neuropsychopharmacology. 34(6). 1454–1466. 17 indexed citations
15.
Chen, Yi-Chyan, Giia‐Sheun Peng, Ming-Fang Wang, Tien‐Ping Tsao, & Shih‐Jiun Yin. (2008). Polymorphism of ethanol-metabolism genes and alcoholism: Correlation of allelic variations with the pharmacokinetic and pharmacodynamic consequences. Chemico-Biological Interactions. 178(1-3). 2–7. 84 indexed citations
16.
Boyce‐Rustay, Janel M., Kathryn Hefner, Yi-Chyan Chen, et al.. (2008). Desipramine potentiation of the acute depressant effects of ethanol: Modulation by α2-adrenoreceptors and stress. Neuropharmacology. 55(5). 803–811. 19 indexed citations
17.
Chen, Yi-Chyan, et al.. (2007). Comparisons of glucose–insulin homeostasis following maprotiline and fluoxetine treatment in depressed males. Journal of Affective Disorders. 103(1-3). 257–261. 23 indexed citations
18.
Shen, Yu‐Chih, Yi-Chyan Chen, Giia‐Sheun Peng, & Wei‐Wen Lin. (2005). Risperidone - Related Unilateral Rubral Tremor in a Manic Patient—A Case Report. 17(6). 437–439. 1 indexed citations
19.
Chen, Shao‐Yuan, et al.. (2003). Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB × NZW) F1 mice. Clinical Immunology. 108(2). 103–110. 23 indexed citations
20.
Lai, Ching‐Long, et al.. (2000). No Sex and Age Influence on the Expression Pattern and Activities of Human Gastric Alcohol and Aldehyde Dehydrogenases. Alcoholism Clinical and Experimental Research. 24(11). 1625–1632. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nuria García‐Marchena Breakdown of academic impact, for papers by Curtis A. Benson Breakdown of academic impact, for papers by Sixun Yu Breakdown of academic impact, for papers by Michal Taler Breakdown of academic impact, for papers by Nóra Török Breakdown of academic impact, for papers by Arezo Nahavandi Breakdown of academic impact, for papers by Xu Wu Breakdown of academic impact, for papers by Timothy Fabisiak Breakdown of academic impact, for papers by Elisa Bisicchia Breakdown of academic impact, for papers by Joan B. O’Sullivan
Rankless by CCL
2026